Evidence map›Paper›PMID 36877291›Full record

ArticleInternational journal of clinical pharmacy2023

How to write a successful grant application: guidance provided by the European Society of Clinical Pharmacy.

Anita E Weidmann, Cathal A Cadogan, Daniela Fialová, Ankie Hazen, Martin Henman, Monika Lutters, Betul Okuyan, Vibhu Paudyal, Francesca Wirth

Open access · hybridAbstract read
In one paragraph

Article in International journal of clinical pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [How to: apply for funding].Die Ophthalmologie · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 8 countries.

Anita E WeidmannDepartment of Clinical Pharmacy, Innsbruck University, Innsbruck, Austria. Anita.Weidmann@uibk.ac.at.ORCID http://orcid.org/0000-0003-3670-2357
Cathal A CadoganSchool of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland.
Daniela FialováDepartment of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
Ankie HazenJulius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Martin HenmanTrinity College Dublin, Dublin, Ireland.
Monika LuttersKantonsspital Aarau, Aarau, Switzerland.
Betul OkuyanDepartment of Clinical Pharmacy, Faculty of Pharmacy, Marmara University, Istanbul, Turkey.
Vibhu PaudyalUniversity of Birmingham, Birmingham, United Kingdom.
Francesca WirthDepartment of Pharmacy, University of Malta, Msida, Malta.
Trinity College Dublin · IECharles University · CZKantonsspital Aarau · CHMarmara University · TRUniversität Innsbruck · ATUniversity Medical Center Utrecht · NLUniversity of Birmingham · GBUniversity of Malta · MT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering a rejection rate of 80-90%, the preparation of a research grant is often considered a daunting task since it is resource intensive and there is no guarantee of success, even for seasoned researchers. This commentary provides a summary of the key points a researcher needs to consider when writing a research grant proposal, outlining: (1) how to conceptualise the research idea; (2) how to find the right funding call; (3) the importance of planning; (4) how to write; (5) what to write, and (6) key questions for reflection during preparation. It attempts to explain the difficulties associated with finding calls in clinical pharmacy and advanced pharmacy practice, and how to overcome them. The commentary aims to assist all pharmacy practice and health services research colleagues new to the grant application process, as well as experienced researchers striving to improve their grant review scores. The guidance in this paper is part of ESCP's commitment to stimulate "innovative and high-quality research in all areas of clinical pharmacy".

Indexed as

PharmacyPharmacy Service, HospitalFinancing, OrganizedHumansResearch DesignWritingClinical pharmacyEconomicsFundingGrantsPeer reviewWriting

Identifiers

PMID36877291
PMCPMC10250258
OpenAlexW4323293953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.